Total Funding
34
48
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
240564
Saccade Diagnostics brings objective tests for psychiatric disorders in patients with mental health complaints.
- Philip Benson: CTO
- David St Clair: Founder
About the Company
Saccade Diagnostics brings to market for the first time clinically-validated objective tests to help clinicians with diagnostic evaluation and management of psychiatric disorders in patients with mental health complaints.
A spin-out from the University of Aberdeen, Saccade has devised a rapid eye-movement test called SaccScan that can help medical
professionals diagnose a range of psychiatric disorders, such as schizophrenia, bipolar disorder and major depression within just 30 minutes. It is non-invasive, affordable and easy to administer, allowing non-specialists to operate it with minimal training.
The academic founders, Philip Benson and David St Clair, teamed up with Madhu Nair, who took on the role of commercial champion and CEO.
